Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Jan 19;187(2):271-5.
doi: 10.1084/jem.187.2.271.

Proteolytic cleavage of CD25, the alpha subunit of the human T cell interleukin 2 receptor, by Der p 1, a major mite allergen with cysteine protease activity

O Schulz  1 , H F Sewell, F Shakib
Affiliations

Proteolytic cleavage of CD25, the alpha subunit of the human T cell interleukin 2 receptor, by Der p 1, a major mite allergen with cysteine protease activity

O Schulz et al. J Exp Med. .

Abstract

Recent reports have indicated that the cysteine protease activity of Der p 1 may play a significant role in its ability to elicit IgE antibody responses, mainly through cleavage of membrane CD23 on B cells and interleukin (IL)-4 synthesis and secretion from mast cells and basophils. Here we demonstrate for the first time that Der p 1 also cleaves the alpha subunit of the IL-2 receptor (IL-2R or CD25) from the surface of human peripheral blood T cells and, as a result, these cells show markedly diminished proliferation and interferon gamma secretion in response to potent stimulation by anti-CD3 antibody. Given that the IL-2R is pivotal for the propagation of Th1 cells, its cleavage by Der p 1 may consequently bias the immune response towards Th2 cells, thereby creating an allergic microenvironment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The proteolytic effect of Der p 1 on human T cell surface markers. Paired results represent the expression of markers in the absence (open bars) and presence (solid bars) of Der p 1 (5 μg/ml). Data presented are the means of duplicate experiments; SE was <5%.
Figure 2
Figure 2
(a) Der p 1–induced cleavage of membrane CD25 (filled circles) and concomitant release of soluble CD25 (open circles). (b) CD25 cleavage is blocked by earlier treatment of Der p 1 (5 μg/ml) with antipain (4 μM). Data presented in a and b are the means of duplicate experiments; SE was <5%.
Figure 2
Figure 2
(a) Der p 1–induced cleavage of membrane CD25 (filled circles) and concomitant release of soluble CD25 (open circles). (b) CD25 cleavage is blocked by earlier treatment of Der p 1 (5 μg/ml) with antipain (4 μM). Data presented in a and b are the means of duplicate experiments; SE was <5%.
Figure 3
Figure 3
Der p 1 suppresses human T cell proliferation mostly within 18–48 h of culture initiation. Results represent cultures with no Der p 1 (open bar) or those to which Der p 1 (10 μg/ml) was added at different time points (solid bars). The thymidine label was added 80 h after culture initiation. Data presented are the means of quadruplicate experiments; error bars represent SEM.
Figure 4
Figure 4
Effect of Der p 1 (10 μg/ml; added 6 h after culture initiation) on the time course of Th1 cytokine expression and soluble CD25 release. Data represent the kinetics of IL-2 expression (a) soluble CD25 release (b), and IFN-γ expression (c) in the absence (open circles) and presence (filled circles) of Der p 1. Data presented are the means of duplicate experiments; SE was <5%.
Figure 4
Figure 4
Effect of Der p 1 (10 μg/ml; added 6 h after culture initiation) on the time course of Th1 cytokine expression and soluble CD25 release. Data represent the kinetics of IL-2 expression (a) soluble CD25 release (b), and IFN-γ expression (c) in the absence (open circles) and presence (filled circles) of Der p 1. Data presented are the means of duplicate experiments; SE was <5%.
Figure 4
Figure 4
Effect of Der p 1 (10 μg/ml; added 6 h after culture initiation) on the time course of Th1 cytokine expression and soluble CD25 release. Data represent the kinetics of IL-2 expression (a) soluble CD25 release (b), and IFN-γ expression (c) in the absence (open circles) and presence (filled circles) of Der p 1. Data presented are the means of duplicate experiments; SE was <5%.
See this image and copyright information in PMC

References

    1. Schulz O, Laing P, Sewell HF, Shakib F. Der pI, a major allergen of the house dust mite, proteolytically cleaves the low-affinity receptor for human IgE (CD23) Eur J Immunol. 1995;25:3191–3194. - PubMed
    1. Schulz O, Sutton BJ, Beavil RL, Shi J, Sewell HF, Gould HJ, Laing P, Shakib F. Cleavage of the low affinity receptor for human IgE (CD23) by a mite cysteine protease: nature of the cleaved fragment in relation to the structure and function of CD23. Eur J Immunol. 1997;27:584–588. - PubMed
    1. Hewitt CRA, Brown AP, Hart BJ, Pritchard DI. A major house dust mite allergen disrupts the immunoglobulin E network by selectively cleaving CD23: innate protection by antiproteases. J Exp Med. 1995;182:1537–1544. - PMC - PubMed
    1. Flores-Romo L, Shields J, Humbert Y, Graber P, Aubry J-P, Gauchat J-F, Ayala G, Allet B, Chavez M, Bazin H, Capron M, Bonnefoy J-Y. Inhibition of an in vivo antigen-specific IgE response by antibodies to CD23. Science. 1993;261:1038–1041. - PubMed
    1. Yu P, Kosco-Vilbois M, Richards M, Kohler G, Lamers MC. Negative feedback regulation of IgE synthesis by murine CD23. Nature. 1994;369:753–756. - PubMed

Publication types

MeSH terms